13th Munich Cancer Retreat

We had the pleasure of contributing to the 13th Munich Cancer Retreat, the annual gathering of the German Cancer Consortium (DKTK). The event brought together researchers from across the Munich cancer research community for inspiring talks, substantive discussions, and valuable networking.

Our Contributions

Translational Research in Glioblastoma

Our PhD student Ilka Klose presented recent progress from PRIDE-T, a translational study accompanying the PRIDE clinical trial. Funded by the Bavarian Center for Cancer Research (BZKF) and the German Cancer Help Foundation (DKH), the study investigates isotoxic dose escalation strategies in glioblastoma, bridging basic science and clinical practice.

Tumor Microenvironment and Immunotherapy Response

Our postdoc Robert Piecyk showcased his work characterizing transcriptome-defined tumor microenvironment subtypes in head and neck squamous cell carcinoma. His analysis reveals how these subtypes predict clinical outcomes following radiotherapy, chemotherapy, and immune checkpoint inhibition—insights with direct implications for treatment personalization.